Cellular models


Cultured human cells constitute a comprehensive unit that enables functional analysis. The Fluofarma drug discovery process is wholly founded on cell-based assays, which means that compounds are tested in a physiological context.

 






With Fluofarma,
Use cell-based assays during all your R&D
Choose beyond doubt the ’right lead’





Fluofarma developed predictive cellular models including:

Panel of human cancer cell lines representative of major tumor types

Engineered cell lines overexpressing specific targets for focused screening

Cell lines expressing recombinant biosensors for specific molecular analysis

► Primary cultures of neurons for drug discovery and neurotoxicity testing

► Microalgae used as an eco-reporter system for ecotoxicity assessment

Breaking news

  • Scientific Publication

    Fluofarma is glad to announce a new scientific publication in the journal Biochimica et Biophysica Acta - Molecular Cell Research.

    Read more [+]

  • IFSCC 2008

    Fluofarma will be attending IFSCC 2008, in Barcelona, from October 6th to 9th.

    Read more [+]

  • INVITOX 2008

    Fluofarma will be attending the INVITOX 2008 meeting, in Stockholm from September 25th to 28th.

    Read more [+]

  • EuroBio 2008

    Fluofarma will be attending EuroBio 2008, in Paris from October 7th to 9th.

    Read more [+]

  • SMi's Cell-Based Assays 2008

    Fluofarma will be attending SMi's Cell-Based Assays conference, in London from November 19th to 20th.

    Read more [+]

  • GDDI Forum 2009

    Fluofarma will be attending Global Discovery & Development Innovation Forum 2009, in London, from March 2nd to 3rd.

    Read more [+]

FOCUS: Anticancer drugs profiling
Fluofarma has developed DCffer® method, a powerful approach to compare and profile your anti-cancer drugs. Read more [+]